Jeffrey T. L. Smith, Managing Director at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 10,080 shares at $13.42 ($135K) on 2018-11-01, disclosed to the SEC on 2018-11-05.
Seasonal sale ($135k) by Managing Director — this insider has traded ALDR in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.42 | 5,040 | $68K | 50.0% |
| 2 | $13.42 | 5,040 | $68K | 50.0% |
| Total | $13.42 avg | 10,080 | $135K | 100% |
| Filing → |
| ZYME | SELL | 2025-01-06 | $332K | — | Filing → |
| ALDR | SELL | 2019-09-18 | $1.2M | — | Filing → |
| ALDR | SELL | 2018-12-04 | $140K | — | Filing → |